apollo
0
Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Ipca Laboratories Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About Rapilif-M 50 Combipack

Rapilif-M 50 Combipack is used for the treatment of Benign prostatic hyperplasia (BPH), a condition in men that causes the enlargement of the prostate gland. It is complicated by an overactive bladder and symptoms of urge urinary incontinence (involuntary leakage of urine), urgency, and frequency.

Rapilif-M 50 Combipack contains Mirabegron and Silodosin. Mirabegron works by reducing the activity of an overactive bladder and treats related symptoms. Silodosin works by relaxing the muscles around the bladder exit and prostate gland. Thus, it makes it easier to pass urine and helps relieve urinary symptoms.

Take Rapilif-M 50 Combipack as prescribed. Your doctor will advise you on how often you should take it based on your medical condition. Rapilif-M 50 Combipack may cause common side effects such as abnormal ejaculation, increased heart rate, dizziness, nausea, constipation, urinary tract infections, and runny or blocked nose. Most of these side effects of Rapilif-M 50 Combipack do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.

If you are allergic to Mirabegron, Silodosin, or any other medicines, please tell your doctor. Rapilif-M 50 Combipack is not recommended for children and adolescents under 18 years of age. Drive only if you are alert after taking Rapilif-M 50 Combipack, as it may cause dizziness. If you are about to undergo cataract eye surgery, inform your eye specialist that you are taking Rapilif-M 50 Combipack, as it may cause complications during the surgery.

Uses of Rapilif-M 50 Combipack

Treatment of Benign prostatic hyperplasia (BPH)

Medicinal Benefits

Rapilif-M 50 Combipack contains Mirabegron and Silodosin. Mirabegron is a bladder muscle relaxant which works by reducing the activity of an overactive bladder and treats related symptoms such as frequent urination, urgency incontinence (an uncontrollable urge to urinate) and sudden need to empty the bladder. Silodosin works by relaxing the muscles around the bladder exit and prostate gland. Thus, it makes it easier to pass urine and helps relieve urinary symptoms such as incomplete bladder emptying, frequent urination at night and difficulty urinating. Thus, together, they help treat benign prostatic hyperplasia (BPH) symptoms.

Side Effects of Rapilif-M 50 Combipack

  • Abnormal ejaculation
  • Increased heart rate
  • Dizziness
  • Nausea
  • Constipation
  • Urinary tract infections
  • Runny or blocked nose
     

Directions for Use

Take Rapilif-M 50 Combipack as advised by the doctor. Swallow it whole with a glass of water. Do not crush, chew, or break it.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

If you are allergic to Mirabegron, Silodosin or any other medicines, please tell your doctor. Rapilif-M 50 Combipack is not recommended for children and adolescents below 18 years of age. Drive only if you are alert after taking Rapilif-M 50 Combipack as it may cause dizziness. If you are about to undergo cataract eye surgery, inform your eye specialist that you are taking Rapilif-M 50 Combipack as it may cause complications during the surgery. Inform your doctor if you take other medicines for overactive bladder treatment. If you get headaches, especially sudden, migraine-like (throbbing) headaches, tell your doctor, as these may be signs of severe high blood pressure.

Therapeutic Class

BPH AGENTS

Drug Interactions

Drug-Drug Interaction: Inform your doctor if you are taking antipsychotics (thioridazine), medicines for abnormal heart rhythm (propafenone, flecainide), antidepressants (desipramine, imipramine), blood thinners (dabigatran etexilate), medicines used to lower blood pressure (doxazosin, prazosin), antifungals (ketoconazole, itraconazole), medicines used for HIV-AIDS (ritonavir), and immunosuppressants (cyclosporine).
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have ever fainted or felt dizzy when standing up suddenly, have trouble emptying your bladder or have a weak urine stream, kidney or liver problems or an ECG abnormality known as QT prolongation, inform your doctor before taking Rapilif-M 50 Combipack.

Drug-Drug Interactions Checker List

  • THIORIDAZINE
  • PROPAFENONE
  • FLECAINIDE
  • DESIPRAMINE
  • IMIPRAMINE
  • DABIGATRAN ETEXILATE
  • DOXAZOSIN
  • PRAZOSIN
  • KETOCONAZOLE
  • ITRACONAZOLE
  • RITONAVIR
  • CYCLOSPORINE

Diet & Lifestyle Advise

  • Avoid caffeine and alcohol, especially in the hours after dinner.
  • Urinate as soon as you feel the urge.
  • Go to the washroom even when you don’t feel the urge.
  • Reduce your stress levels, as nervousness may increase urination frequency.
  • Keep yourself warm since being cold may worsen symptoms.
     

Habit Forming

No

What if I have taken an overdose of Rapilif-M 50 Combipack

Do not take more than the prescribed dose. Using more medication will not improve symptoms; instead, they may cause serious adverse effects such as Increased pulse rate, systolic blood pressure, and hypotension. If you suspect that you or anyone else who may have overdosed of Rapilif-M 50 Combipack, please go to the emergency department of the closest hospital.

Disease/Condition Glossary

Benign prostatic hyperplasia (BPH): It is a condition in men in which age-related prostate gland enlargement occurs, which may cause urination difficulty. It occurs when the prostate gland's cells start to multiply. Your prostate gland swells due to these extra cells, which squeeze the urethra and decrease urine flow. The exact cause is unknown, but age-related changes in male sex hormones may be a factor. Any testicular abnormalities or a family history of prostate issues could increase the risk of developing BPH. The symptoms include excessive urination at night, dribbling (to move downwards in a thin flow) after urination, a sense of incomplete bladder emptying, an urge to urinate and leaking, frequent urination and a weak urinary stream.

bannner image

Alcohol

Consult your doctor

The interaction of Rapilif-M 50 Combipack with alcohol is unknown. If you have any concerns, discuss them with your doctor.

bannner image

Pregnancy

Not applicable

Rapilif-M 50 Combipack is recommended for use in men.

bannner image

Breast Feeding

Not applicable

Rapilif-M 50 Combipack is recommended for use in men.

bannner image

Driving

Caution

Rapilif-M 50 Combipack may cause dizziness in some people. Therefore, avoid driving if you feel dizzy after taking Rapilif-M 50 Combipack.

bannner image

Liver

Consult your doctor

If you are suffering from liver diseases or conditions, inform your doctor before taking Rapilif-M 50 Combipack. Your doctor may adjust the dose as necessary.

bannner image

Kidney

Consult your doctor

If you are suffering from kidney diseases or conditions, inform your doctor before taking Rapilif-M 50 Combipack. Your doctor may adjust the dose as necessary.

bannner image

Children

Unsafe

Rapilif-M 50 Combipack is not recommended for children and adolescents below 18 years as there is no relevant use for this age group.

Country of origin

India

Manufacturer/Marketer address

142 Ab, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra
Other Info - RAP0178

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Rapilif-M 50 Combipack is used for the treatment of Benign prostatic hyperplasia (BPH) complicated by overactive bladder with symptoms of urge urinary incontinence (involuntary leakage of urine), urgency, and frequency.
Rapilif-M 50 Combipack contains Mirabegron and Silodosin. Mirabegron reduces the activity of an overactive bladder and treats related symptoms. Silodosin relaxes the muscles around the bladder exit and prostate gland. Thus, it makes it easier to pass urine and helps relieve urinary symptoms.
Low blood pressure, especially when starting to take Rapilif-M 50 Combipack, may cause dizziness when standing up suddenly from a sitting or lying position. Therefore, to avoid such effects, it is advised to stand up slowly from a sitting or lying position. Regular blood pressure monitoring is recommended at the beginning of therapy to reduce the possibility of such effects.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Add to Cart